Literature DB >> 9406343

The development of a multivalent DNA vaccine for malaria.

R C Hedstrom1, D L Doolan, R Wang, M J Gardner, A Kumar, M Sedegah, R A Gramzinski, J B Sacci, Y Charoenvit, W R Weiss, M Margalith, J A Norman, P Hobart, S L Hoffman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9406343     DOI： 10.1007/bf00870265

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  59 in total

1.  Structure of Plasmodium falciparum liver stage antigen-1.

Authors:  J Zhu; M R Hollingdale
Journal:  Mol Biochem Parasitol       Date:  1991-10       Impact factor: 1.759

2.  Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages.

Authors:  L Rénia; D Grillot; M Marussig; G Corradin; F Miltgen; P H Lambert; D Mazier; G Del Giudice
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

3.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells.

Authors:  P Panina-Bordignon; A Tan; A Termijtelen; S Demotz; G Corradin; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

4.  Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge.

Authors:  L W Church; T P Le; J P Bryan; D M Gordon; R Edelman; L Fries; J R Davis; D A Herrington; D F Clyde; M J Shmuklarsky; I Schneider; T W McGovern; J D Chulay; W R Ballou; S L Hoffman
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

5.  Genetic control of immunity to Plasmodium yoelii sporozoites.

Authors:  W R Weiss; M F Good; M R Hollingdale; L H Miller; J A Berzofsky
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

6.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Authors:  W A Siddiqui; L Q Tam; K J Kramer; G S Hui; S E Case; K M Yamaga; S P Chang; E B Chan; S C Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.

Authors:  S L Hoffman; C N Oster; C V Plowe; G R Woollett; J C Beier; J D Chulay; R A Wirtz; M R Hollingdale; M Mugambi
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

8.  Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.

Authors:  R R Freeman; A A Holder
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

9.  Complete protection against Plasmodium yoelii by adoptive transfer of a CD8+ cytotoxic T-cell clone recognizing sporozoite surface protein 2.

Authors:  S Khusmith; M Sedegah; S L Hoffman
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.

Authors:  W R Weiss; S Mellouk; R A Houghten; M Sedegah; S Kumar; M F Good; J A Berzofsky; L H Miller; S L Hoffman
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307
View more
  3 in total

1.  Immune responses induced by gene gun or intramuscular injection of DNA vaccines that express immunogenic regions of the serine repeat antigen from Plasmodium falciparum.

Authors:  A A Belperron; D Feltquate; B A Fox; T Horii; D J Bzik
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.

Authors:  A T Kamath; C G Feng; M Macdonald; H Briscoe; W J Britton
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

3.  Measuring the effects of an ever-changing environment on malaria control.

Authors:  Thomas F McCutchan; K Christiana Grim; Jun Li; Walter Weiss; Darmendar Rathore; Margery Sullivan; Thaddeus K Graczyk; Sanjai Kumar; Mike R Cranfield
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.